NCT07211386

Brief Summary

This study will target patients with gastrointestinal (GI) malignancy who present to any of 4 Penn Medicine emergency departments (EDs) with intractable abdominal pain. We will offer eligible patients an erector spinae plane block (ESPB), a regional anesthesia technique which is already offered to such patients in the ED at the University of Pennsylvania Healthy System (UPHS), for their intractable abdominal pain. We will compare the outcomes of this prospective cohort of patients to a matched historical control of patients with GI malignancy who were treated in the ED during the same time period as recruitment, but who were not recruited to partake in the study and who were managed with standard of care. Opioid consumption as measured by total milligram morphine equivalents (MMEs) over a 24-hour period and hospital length of stay (LOS) will be compared between cohorts. Additionally, for the ESPB cohort, pain level pre/post ESPB, and functionality and satisfaction with pain management at 24 hours will also be examined.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Dec 2025

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Dec 2025Jun 2027

First Submitted

Initial submission to the registry

October 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

December 11, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2027

Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.4 years

First QC Date

October 1, 2025

Last Update Submit

November 24, 2025

Conditions

Keywords

Gastrointestinal malignancypain controlnerve block

Outcome Measures

Primary Outcomes (2)

  • Opioid Consumption

    We will track the amount of opioids consumed within 24 hours by patients who received the erector spinae plane block

    24 hours

  • Opioid Consumption

    We will track the amount of opioids consumed within 24 hours by participants who receive the erector spinae plane block.

    24 hours

Secondary Outcomes (3)

  • Length of Stay

    1 week

  • Pain Levels

    30 minutes

  • Revised American Pain Society Patient Outcome Questionnaire

    24 hours

Study Arms (1)

Treatment Arm -- Erector Spinae Plane Block

EXPERIMENTAL

Patients with gastrointestinal malignancy and abdominal pain will receive the erector spinae plane block for their abdominal pain.

Procedure: Erector Spinae Plane Block

Interventions

The abdominal viscera, from the stomach to midway through the sigmoid colon, derives its sensory innervation from afferent fibers that travel with, but are distinct from, the sympathetic nerve fibers from the 5th thoracic (T5) to the 2nd lumbar (L2) spinal levels (Moore et al). These fibers converge at the celiac plexus, located near the celiac artery and the aorta. From there, they bifurcate into the paravertebral sympathetic chain and subsequently ascend to the spinal cord and integrate into the central nervous system (Lohse et al). The celiac plexus block is an invasive procedure performed by an interventional anesthesiologist or palliative care specialist to lyse the celiac plexus and has been shown to reduce pain and opiate use in patients suffering from GI malignancy (Ashlock et al). While there are multiple methods to perform a celiac plexus block, it involves a steep needle trajectory either posteriorly through the retroperitoneum or anteriorly through the abdominal wall close

Treatment Arm -- Erector Spinae Plane Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients age \> 18 years old with GI malignancy presenting to a Penn Medicine ED with intractable abdominal pain.
  • Same-day or recent CT scan of the abdomen / pelvis which demonstrates that the patient's abdominal pain can be reasonably attributed to a malignant source.

You may not qualify if:

  • Allergy to ropivacaine or history of local anesthetic systemic toxicity.
  • Pregnancy
  • Incarcerated
  • Patients being admitted for serial abdominal examinations to determine their surgical course.
  • Altered mental status or inability for patient to consent for the procedure
  • Hemodynamic instability
  • Previously enrolled in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Pennsylvania Hospital

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

Hospital of the University of Pennsylvania -- Cedar Avenue

Philadelphia, Pennsylvania, 19143, United States

RECRUITING

Related Publications (2)

  • Gawel RJ, Kramer JA, Shalaby M. Ultrasound-Guided Erector Spinae Plane Block for Breakthrough Pancreatic and Hepatobiliary Malignancy Pain in the Emergency Department: A Case Series. Clin Pract Cases Emerg Med. 2025 May;9(2):129-133. doi: 10.5811/cpcem.39723.

    PMID: 40402045BACKGROUND
  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451.

    PMID: 27501016BACKGROUND

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Shalaby, MD

    University of Pennsylvania Department of Emergency Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 25 patients with gastrointestinal malignancy and abdominal pain who present to any of the four emergency departments within the University of Pennsylvania Health System will be recruited to participate in the study. These patients will have their pain treated with the erector spinae plane block.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Emergency Medicine

Study Record Dates

First Submitted

October 1, 2025

First Posted

October 8, 2025

Study Start

December 11, 2025

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

June 15, 2027

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations